Ralph Passarella is the CEO and Co-Founder of Reify Health, where he and his team are working to accelerate the development of new, life-saving therapies.
What does Reify Health do?
Reify offers clinical trial tech infrastructure and support through two brands, StudyTeam and Care Access. StudyTeam is cloud-based software for study sites and sponsors to assist in recruiting, pre-screening and enrolling patients in clinical trials.
Who owns Reify?
Ralph Passarella and Michael Lin co-founded Reify in 2012 with a goal of slashing the amount of time it takes to enroll patients in a clinical trial to three months from an average of about 18 months.
What kind of company is reify health?
Reify Health, Inc. provides health care technology solutions. The Company offers clinical optimization software, with a focus on patient enrollment and transformative clinical trial infrastructure that delivers research directly to more healthcare providers, communities, and patients.
Who is the CEO of reify health? – Related Questions
Where is reify Health located?
Reify Health was founded in 2012. Where is Reify Health’s headquarters? Reify Health’s headquarters is located at 33 Arch Street, Boston.
Who invested in devoted Health?
Who invested in Devoted Health ? Devoted Health has 26 investors including General Catalyst and GIC . How much funding has Devoted Health raised to date? Devoted Health has raised $2B .
What industry is Signant health?
Signant Health operates as a software company. The Company offers clinical supplies, endpoint quality, and patient solutions.
What do Teckro do?
Teckro is the digital clinical trial hub for content, communication and insights. We connect sponsors, monitors and research site staff with the critical study information and guidance they need, when and where they need it, from any digital device.
Is Everside Health a public company?
This is the initial public offering of common stock of Everside Health Group, Inc. We are offering shares of our common stock.
What type of company is Flatiron health?
Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every patient story count.
Who are Flatiron Health competitors?
Flatiron Health’s top competitors include COTA, Tempus, and LifeNome. COTA provides healthcare services for cancer-affected patients.
Why did Roche buy Flatiron?
“This is an important step in our personalized healthcare strategy for Roche, as we believe that regulatory-grade real-world evidence is a key ingredient to accelerate the development of, and access to, new cancer treatments,” said Roche CEO Daniel O’Day in a statement.
Who bought Flatiron health?
Roche has struck a $1.9 billion deal to acquire Flatiron Health. The takeover gives Roche ownership of the cancer software and real-world evidence that turned Google Ventures-backed Flatiron into a rising star.
Is Flatiron Health a good company?
Flatiron Health has an overall rating of 3.9 out of 5, based on over 201 reviews left anonymously by employees. 84% of employees would recommend working at Flatiron Health to a friend and 80% have a positive outlook for the business.
How does Flatiron Health make money?
Flatiron Makes Money from Biopharma
Flatiron’s business model is based on creating a valuable data asset and selling access to that data, primarily to biopharma companies like Roche.
Is Flatiron Health owned by Roche?
Flatiron Health was founded in 2012; it became an independent affiliate of the Roche Group in 2018 following its acquisition by Roche. Flatiron Health is a healthtech company dedicated to helping cancer centres thrive and deliver better care for patients today and tomorrow.
Is Roche owned by Novartis?
The company owns 33% of Roche’s voting shares, and Novartis has made a 10% annual gain on them over the past two decades.
What companies do Roche own?
The company controls the American biotechnology company Genentech, which is a wholly owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States-based companies Ventana and Foundation Medicine.
